Invention Application
- Patent Title: ADJUSTMENT OF MEDICAMENT DELIVERY BY A MEDICAMENT DELIVERY DEVICE BASED ON MENSTRUAL CYCLE PHASE
-
Application No.: US17848675Application Date: 2022-06-24
-
Publication No.: US20230001089A1Publication Date: 2023-01-05
- Inventor: Rangarajan NARAYANASWAMI
- Applicant: INSULET CORPORATION
- Applicant Address: US MA Acton
- Assignee: INSULET CORPORATION
- Current Assignee: INSULET CORPORATION
- Current Assignee Address: US MA Acton
- Main IPC: A61M5/172
- IPC: A61M5/172 ; G16H20/17 ; G16H40/67

Abstract:
Exemplary embodiments account for differing needs of a user over the menstrual cycle of the user to better control the blood glucose concentration of the user. The exemplary embodiments may be realized in control systems for medicament delivery devices that deliver medicaments, such as medicaments that regulate blood glucose concentration levels. Examples of such medicaments that regulate blood glucose concentration levels include insulin, glucagon, and glucagon peptide-1 (GLP-1) agonists. The exemplary embodiments are able to better tailor the dosages of the medicament delivered to the user with the medicament delivery device to reduce the risk of hyperglycemia and hypoglycemia and help reduce blood glucose concentration excursions.
Information query
IPC分类: